Socket Shield Technique With or Without Flap Elevation

February 12, 2024 updated by: Ezgi Gürbüz, Kutahya Health Sciences University

Clinical and Radiographic Evaluation of Socket Shield Technique With or Without Flap Elevation

It is aimed to compare the bone changes and the amount of marginal bone loss after prosthetic loading around the immediately placed implants using the Socket Shield Technique with or without flap elevation.

Study Overview

Detailed Description

Temporary prostheses will be applied to patients in the flap and flapless surgery group 1 week after the surgical procedure, and permanent prostheses will be placed 3 months later. From this date, clinical controls will be made in the 1st, 3rd, 6th months and 1st year.

During these controls, biological complications (peri-implant mucositis, peri-implantitis), implant failure and survival rates, and complications related to the socket shield (socket shield exposure, infection) will be evaluated. Marginal bone loss around the implants and bone resorption in the horizontal and vertical directions will be compared between the two groups with cone beam computed tomography taken at the 1st year follow-up.

The Oral Health-Related Quality of Life Scale will be applied in the session where the temporary prosthesis is applied 1 week after the surgery, in the 1st month clinical control and in the 3rd and 6th month clinical control after the permanent prosthesis application, in order to evaluate the quality of life related to the surgical and prosthetic application of the patients in both groups, and comparisons between groups will be made.

In addition, intraoral photographs will be taken from the patients for aesthetic evaluation before the surgical procedure, at the 1st, 3rd and 6th month clinical control sessions. Pink Aesthetic Score (PES) and White Aesthetic Score (BES) will be evaluated on the photographs, and a comparison will be made between groups in terms of scores.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kütahya, Turkey
        • Kütahya Health Sciences University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 62 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being systemically healthy (ASA classification I-II)
  • Being over 18 years old
  • Not smoking
  • Having good oral hygiene
  • Upper incisors and premolars that cannot be restored and have extraction indications
  • Periodontally healthy, non-mobile teeth
  • The amount and quality of bone suitable for immediate implant placement

Exclusion Criteria:

  • Periodontally unhealthy teeth
  • Teeth with vertical root fracture on the buccal surface
  • Teeth with a horizontal fracture below the bone level
  • Teeth with external and internal resorption affecting the buccal part of the root
  • Patients who are pregnant or suspected of pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Flapless Surgery
Immediate implant surgery applied with the Socket Shield Technique
Active Comparator: Surgery With Flap Elevation
Immediate implant surgery applied with the Socket Shield Technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline marginal bone loss at 12 months
Time Frame: Baseline, 12th month
Measurement of marginal bone loss change between baseline and 12th month by cone beam computed tomography
Baseline, 12th month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of peri-implant pocket depth between baseline and follow-up periods
Time Frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Clinical measurement of change in peri-implant pocket depth between follow-up periods using probe
Baseline, 1st month, 3rd month, 6th month, 12th month
Change of modified plaque index between baseline and follow-up periods
Time Frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Clinical measurement of change in modified plaque index between follow-up periods using probe
Baseline, 1st month, 3rd month, 6th month, 12th month
Change of modified bleeding index between baseline and follow-up periods
Time Frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Clinical measurement of change in modified bleeding index between follow-up periods using probe
Baseline, 1st month, 3rd month, 6th month, 12th month
Change in the width of keratinized mucosa between follow-up periods
Time Frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Clinical measurement of change in the keratinized mucosa width between follow-up periods using probe
Baseline, 1st month, 3rd month, 6th month, 12th month
Change in the mucosal recession between follow-up periods
Time Frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Clinical measurement of change in the mucosal recession between follow-up periods using probe
Baseline, 1st month, 3rd month, 6th month, 12th month
Change in the mucosal thickness between follow-up periods
Time Frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Clinical measurement of change in the mucosal thickness between follow-up periods using spreader
Baseline, 1st month, 3rd month, 6th month, 12th month
Visual analog scale
Time Frame: Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month
On a scale of 0-10, with 0 indicating the worst and 10 indicating the best choice
Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month
Oral health impact profile questionnaire
Time Frame: Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month
A questionnaire consisting of 14 items
Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month
Pink aesthetic score
Time Frame: Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month
An index with a minimum score of 0 and a maximum score of 14
Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month
White aesthetic score
Time Frame: Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month
An index with a minimum score of 0 and a maximum score of 10
Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ezgi Gürbüz, Kütahya Health Sciences University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 18, 2019

Primary Completion (Actual)

December 21, 2023

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

August 3, 2022

First Submitted That Met QC Criteria

August 4, 2022

First Posted (Actual)

August 9, 2022

Study Record Updates

Last Update Posted (Estimated)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 12, 2024

Last Verified

October 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Bone Resorption

Clinical Trials on Immediate implantation with the Socket Shield Technique

3
Subscribe